Literature DB >> 19672190

Role of central and mixed venous oxygen saturation measurement in perioperative care.

Stephen J Shepherd1, Rupert M Pearse.   

Abstract

Complications after major surgery are a leading cause of morbidity and mortality. The etiology of postoperative complications is complex, but poor cardiorespiratory reserve appears to be a key factor. There is increasing interest in the use of central and mixed venous oxygen saturation to guide therapeutic interventions during the perioperative period. However, a detailed understanding of the physiologic principles of venous oximetry is essential for safe and effective use in clinical practice. Venous oxygen saturation reflects the balance between global oxygen delivery and oxygen consumption, which may be affected by a wide range of factors during the perioperative period. The purpose of this article is to describe the physiology and measurement of mixed and central venous oxygen saturation and to explore the findings of clinical investigations of their use in perioperative care.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672190     DOI: 10.1097/ALN.0b013e3181af59aa

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  19 in total

1.  Optimization of oxygen delivery during high-risk surgery: keeping the concept but refining goals for inotrope infusion?

Authors:  Emmanuel Futier; Benoit Vallet
Journal:  Crit Care       Date:  2012-02-06       Impact factor: 9.097

2.  Prospective evaluation of regional oxygen saturation to estimate central venous saturation in sepsis.

Authors:  Christian Koch; Rainer Röhrig; Tobias Monz; Andreas Hecker; Florian Uhle; Emanuel Schneck; Markus A Weigand; Christoph Lichtenstern
Journal:  J Clin Monit Comput       Date:  2015-03-11       Impact factor: 2.502

3.  [Near-infrared spectroscopy in sepsis therapy : predictor of a low central venous oxygen saturation].

Authors:  C Lichtenstern; C Koch; R Röhrig; B Rosengarten; M Henrich; M A Weigand
Journal:  Anaesthesist       Date:  2012-09-27       Impact factor: 1.041

4.  Extending the Scope of 1H NMR-Based Blood Metabolomics for the Analysis of Labile Antioxidants: Reduced and Oxidized Glutathione.

Authors:  G A Nagana Gowda; Vadim Pascua; Daniel Raftery
Journal:  Anal Chem       Date:  2021-10-27       Impact factor: 6.986

5.  Central venous oxygen saturation during cardiopulmonary bypass predicts 3-year survival.

Authors:  Staffan Svenmarker; Sören Häggmark; Margareta Östman; Anders Holmgren; Ulf Näslund
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-10-12

6.  Evolution of haemodynamics and outcome of fluid-refractory septic shock in children.

Authors:  Akash Deep; Chulananda D A Goonasekera; Yanzhong Wang; Joe Brierley
Journal:  Intensive Care Med       Date:  2013-06-28       Impact factor: 17.440

7.  Central venous O₂ saturation and venous-to-arterial CO₂ difference as complementary tools for goal-directed therapy during high-risk surgery.

Authors:  Emmanuel Futier; Emmanuel Robin; Matthieu Jabaudon; Renaud Guerin; Antoine Petit; Jean-Etienne Bazin; Jean-Michel Constantin; Benoit Vallet
Journal:  Crit Care       Date:  2010-10-29       Impact factor: 9.097

8.  Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients.

Authors:  Emmanuel Robin; Emmanuel Futier; Oscar Pires; Maher Fleyfel; Benoit Tavernier; Gilles Lebuffe; Benoit Vallet
Journal:  Crit Care       Date:  2015-05-13       Impact factor: 9.097

9.  Prophylactic Norepinephrine Infusion Reduces Postoperative Complications and Hospitalization Time in Elderly Patients Undergoing Posterior Lumbar Spinal Fusion.

Authors:  Tao Liang; Jianshe Yu; Libiao Li; Yaying Xie; Fan Wu
Journal:  Biomed Res Int       Date:  2021-06-03       Impact factor: 3.411

10.  Use of the PiCCO system in critically ill patients with septic shock and acute respiratory distress syndrome: a study protocol for a randomized controlled trial.

Authors:  Zhongheng Zhang; Xiao Xu; Min Yao; Huilan Chen; Hongying Ni; Haozhe Fan
Journal:  Trials       Date:  2013-02-01       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.